[
1. Srivastava H, Reddy DS, Shah SN, Shah V. Castleman’s disease. J Oral Maxillofac Pathol. 2020;24:593. DOI: 10.4103/jomfp.JOMFP_283_20808344633967527
]Open DOISearch in Google Scholar
[
2. Castleman B, Towne VW. Case records of the Massachusetts General Hospital. Vol. 250. p. 1001-5. DOI: 10.1056/NEJM19540610250230813165944
]Open DOISearch in Google Scholar
[
3. Wu D, Lim MS, Jaffe ES. Pathology of Castleman disease. Hematology/Oncology Clinics. 2018;32:37-52. DOI: 10.1016/j.hoc.2017.09.00429157618
]Open DOISearch in Google Scholar
[
4. Casper C. The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care. Br J Haematol. 2005;129:3-17. DOI: 10.1111/j.1365-2141.2004.05311.x15801951
]Open DOISearch in Google Scholar
[
5. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972;29:670-83. DOI: 10.1002/1097-0142(197203)29:3%3C670::AIDCNCR2820290321%3E3.0.CO;2-%23
]Open DOISearch in Google Scholar
[
6. Oksenhendler E, Boutboul D, Fajgenbaum D, Mirouse A, Fieschi C, Malphettes M, et al. The full spectrum of Castleman disease: 273 patients studied over 20 years. British Journal of Haematology. 2018;180:206-16. DOI: 10.1111/bjh.15019
]Open DOISearch in Google Scholar
[
7. Beckham TH, Yang JC, Chau KW, Noy A, Yahalom J. Excellent outcomes with surgery or radiotherapy in the management of Castleman disease including a case of oligocentric disease. Clinical Lymphoma Myeloma and Leukemia. 2020;20:685-9. DOI: 10.1016/j.clml.2020.05.002
]Open DOISearch in Google Scholar
[
8. Oksenhendler E, Boulanger E, Galicier L, Du MQ, Dupin N, Diss TC, et al. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood. 2002;99:2331-6. DOI: 10.1182/blood.V99.7.2331
]Open DOISearch in Google Scholar
[
9. Glazer M, Rao VM, Reiter D, McCue P. Isolated Castleman disease of the neck: MR findings. AJNR Am J Neuroradiol. 1995;16:669-71.
]Search in Google Scholar
[
10. Menke DM, Tiemann M, Camoriano JK, Chang SF, Madan A, Chow M, et al. Diagnosis of Castleman’s disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies. Am J Clin Pathol. 1996;105:268-76. DOI: 10.1093/ajcp/105.3.268
]Open DOISearch in Google Scholar
[
11. Wojtyś M, Piekarska A, Kunc M, Ptaszyński K, Biernat W, Zaucha JM, et al. Clinicopathological comparison and therapeutic approach to Castleman disease-a case-based review. J Thorac Dis. 2019;11:4859-74. DOI: 10.21037/jtd.2019.10.73
]Open DOISearch in Google Scholar
[
12. Falchi L, Capello D, Palumbo B, Rauco A, Emili R, Cianciulli M, et al. A case of nodular sclerosis Hodgkin’s lymphoma repeatedly relapsing in the context of composite plasma cell-hyaline vascular Castleman’s disease: successful response to rituximab and radiotherapy. Eur J Haematol. 2007;79:455-61. DOI: 10.1111/j.1600-0609.2007.00952.x212112517908180
]Open DOISearch in Google Scholar
[
13. El-Osta HE, Kurzrock R. Castleman’s disease: from basic mechanisms to molecular therapeutics. The Oncologist. 2011;16:497-511. DOI: 10.1634/theoncologist.2010-0212322812221441298
]Open DOISearch in Google Scholar
[
14. Nishi J, Arimura K, Utsunomiya A, Yonezawa S, Kawakami K, Maeno N, et al. Expression of vascular endothelial growth factor in sera and lymph nodes of the plasma cell type of Castleman’s disease. Br J Haematol. 1999;104:482-5. DOI: 10.1046/j.1365-2141.1999.01208.x10086783
]Open DOISearch in Google Scholar
[
15. Mohtaram A, Afif M, Sghiri T, Rami A, Latib R, Kettani F, et al. Coexistence of Hodgkin’s Lymphoma and Castleman’s Disease: A Case Report with Successful Response to Chemotherapy and Radiotherapy. Case Rep Oncol Med. 2013;2013. DOI: 10.1155/2013/487205387012924381772
]Open DOISearch in Google Scholar
[
16. Selvaraj K, Gudipudi D. Recurrent and Hodgkin’s lymphoma-associated multicentric Castleman’s disease in head and neck region. International Journal of Otorhinolaryngology and Head and Neck Surgery. 2020;6:1882. DOI: 10.18203/issn.2454-5929.ijohns20204193
]Open DOISearch in Google Scholar
[
17. Maheswaran PR, Ramsay AD, Norton AJ, Roche WR. Hodgkin’s disease presenting with the histological features of Castleman’s disease. Histopathology. 1991;18:249-53. DOI: 10.1111/j.1365-2559.1991.tb00833.x1675190
]Open DOISearch in Google Scholar
[
18. Zarate-Osorno A, Medeiros LJ, Danon AD, Neiman RS. Hodgkin’s disease with coexistent Castleman-like histologic features. A report of three cases. Arch Pathol Lab Med. 1994;118:270-4.
]Search in Google Scholar
[
19. Gong S, Hijiya N. Classical Hodgkin lymphoma and Castleman disease: a rare morphologic combination. Blood, The Journal of the American Society of Hematology. 2017;130:381. DOI: 10.1182/blood-2017-05-78212828729340
]Open DOISearch in Google Scholar
[
20. Yu L, Tu M, Cortes J, Xu-Monette ZY, Miranda RN, Zhang J, et al. Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease. Blood. 2017;129:1658-68. DOI: 10.1182/blood-2016-11-748855536434328100459
]Open DOISearch in Google Scholar
